BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11550156)

  • 1. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas.
    Sasaki H; Dai M; Auclair D; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y; Chen LB
    Cancer; 2001 Aug; 92(4):843-8. PubMed ID: 11550156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.
    Sasaki H; Yu CY; Dai M; Tam C; Loda M; Auclair D; Chen LB; Elias A
    Breast Cancer Res Treat; 2003 Feb; 77(3):245-52. PubMed ID: 12602924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients.
    Sasaki H; Dai M; Auclair D; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y; Chen LB
    Cancer Lett; 2001 Oct; 172(1):37-42. PubMed ID: 11595127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.
    Sasaki H; Lo KM; Chen LB; Auclair D; Nakashima Y; Moriyama S; Fukai I; Tam C; Loda M; Fujii Y
    Jpn J Cancer Res; 2001 Aug; 92(8):869-73. PubMed ID: 11509119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro.
    Hong L; Sun H; Lv X; Yang D; Zhang J; Shi Y
    Mol Biol Rep; 2010 Jun; 37(5):2285-93. PubMed ID: 19688273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of periostin isoform pattern in non-small cell lung cancer.
    Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
    Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women.
    Sasaki H; Roberts J; Lykins D; Fujii Y; Auclair D; Chen LB
    Am J Obstet Gynecol; 2002 Jan; 186(1):103-8. PubMed ID: 11810094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic value of serum periostin in advanced non-small cell lung cancer patients receiving chemotherapy.
    Zhang Y; Yuan D; Yao Y; Sun W; Shi Y; Su X
    Tumour Biol; 2017 May; 39(5):1010428317698367. PubMed ID: 28459197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periostin Expression in Non-Small Cell Lung Cancer: Clinical Significance.
    Murakami D; Takamori S; Kawahara A; Mitsuoka M; Kashihara M; Yoshiyama K; Matsumoto R; Yokoyama S; Fujimoto K; Kawaguchi A; Izuhara K; Akagi Y
    Kurume Med J; 2018 Feb; 64(1.2):13-20. PubMed ID: 29176296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
    Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
    Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.